Study | Number | Time to testing | GCS score | Test used | Neuroendocrine axis assessed | ||||
Adrenal | GH | Thyroid | Gonadal | Prolactin | |||||
Feibel,20 1983 | 23 | 12–36 h | <8 | Basal ACTH + cortisol | ↑Cortisol despite ↑ dose dexamethasone | N/A | N/A | N/A | N/A |
Hackl,21 1991 | 21 | Acute phase | <6 or >6 | Basal, TRH + arginine stimulation | ↑ Cortisol | Impaired response to arginine stimulation | ↑ T4 | N/A | Low |
Della Corte,22 1998 | 22 | Day 1–5, Day 15+16 | 4–8 | Basal, GHRH + TRH stimulation | ↓ Cortisol day 2–7 | ↑ IGF-1 day 7+15 Exaggerated GH response to GHRH | TSH+T4 normal T3 low | N/A | Unchanged |
Cernak,23 1999 | 18/31 | 7 days | 13–15 (n = 8) Closed injury | Basal | ↑ Cortisol day 1+2 | N/A | ↑TSH day 1–3, ↑T3 day 1,5,7, T4 unchanged | ↓Testosterone | N/A |
4–6 (n = 10) Penetrating injury | Basal | ↓ Cortisol day 1–3, ↑ Cortisol day 5–7 | N/A | ↓TSH day 1–7, ↓T3 day 1–7, T4 unchanged | ↓Testosterone day 1–7 | N/A | |||
Agha,24 2004 | 50 | 12 days median | 3–13 | Basal + GST | 16% deficient | 18% deficient | 2% deficient | 80% deficient | 52% high |
Cohan,25 2005 | 80 | 1–9 days | 3–13 | ACTH + cortisol | 53% insufficient | N/A | N/A | N/A | N/A |
Tanriverdi,26 2006 | 52 | 24 h | 3–15 | Basal | 9.8% deficient | 20.4% deficient | 5.8% deficient | 41.6% deficient | 12% high |
ACTH, adrenocorticotropin hormone; GCS, Glasgow Coma Scale; GH, growth hormone; GHRH, growth-hormone-releasing hormone; GST, glucagon stimulation test; IGF-1, insulin-like growth factor 1; N/A, not available; T3, triiodothyronine; T4, thyroxine; TRH, thyrotropin-releasing hormone; TSH, thyroid-stimulating hormone.